MediWound Ltd. (MDWD) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
MDWD currently has 10.8M outstanding shares. with significant dilution risk as 9.21M authorized shares could dilute existing holders by 85.3%. The company has minimally diluted shareholders by 0.06% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Mar 19, 2025 |
F-3 filing: MediWound Ltd. is offering Ordinary Shares, Warrants and/or Debt Securities, Separately and/or Units, Offered by the Company, as well as up to 1,266,141 Ordinary Shares Offered by the Selling Shareholder. |
11M | 9.2M |
| Mar 19, 2025 |
20-F filing | 10.8M shares outstanding |
11M | 9.2M |
| Aug 29, 2024 |
F-3 filing: Resale of up to 1,453,488 ordinary shares by selling shareholders. |
11M | 1.5M |
| Mar 21, 2024 |
20-F filing | 9.2M shares outstanding |
9.2M | 0 |
| Mar 31, 2023 |
POS AM filing: This POS AM filing registers the resale of up to 4,021,880 ordinary shares by selling shareholders, consisting of shares issuable upon exercise of warrants. |
9.2M | 0 |
| Mar 16, 2023 |
20-F filing | 7.2M shares outstanding |
7.2M | 28M |
| Nov 10, 2022 |
F-1 filing: This F-1 filing registers the resale of up to 28,153,058 ordinary shares by selling shareholders, consisting of shares issued or issuable upon exercise of pre-funded warrants, series A warrants, registered direct series A warrants and warrants issued to H.C. Wainwright & Co., LLC as compensation. |
41M | 28M |
| Mar 17, 2022 |
20-F filing | 27.3M shares outstanding |
27M | 0 |
| Feb 25, 2021 |
20-F filing | 27.2M shares outstanding |
27M | 0 |
| Feb 25, 2020 |
20-F filing | 27.2M shares outstanding |
27M | 0 |